4 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Placebo 2: new trials by email Literature Review of Placebo 2 trials Research Report on Placebo 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm Carbidopa 25 mg, Carbidopa-Levodopa 25/100 mg, Placebo 1 - Parkinsonian Signs in Older Persons | Phase 1 / Phase 2 | Completed | University of Michigan | 13 | 2024-03-15 | 2025-06-17 |
| An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic Patients VTP-43742, Placebo 1, Placebo 2 - Psoriasis | Phase 1 / Phase 2 | Completed | Vitae Pharmaceuticals Inc., an Allergan affiliate | 74 | 2015-08-01 | 2018-10-30 |
| A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453 LFX453 H1, LFX453 L1, LFX453 H2 - Healthy | Phase 1 | Completed | Novartis Pharmaceuticals | 41 | 2014-01-01 | 2015-05-15 |
| Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males Lacosamide, Placebo 3, Placebo 4 - Healthy Volunteers | Phase 1 | Completed | UCB Pharma | 33 | 2011-03-01 | 2011-08-23 |
Psoriasis (1)
Novartis Pharmaceuticals (1) · UCB Pharma (1) · University of Michigan (1) · Vitae Pharmaceuticals Inc., an Allergan affiliate (1)
United States (2) · Germany (1) · United Kingdom (1)
Chatkaew Pongmala, PhD (1) · Richard Gregg, MD (1)
U01AG061393 (1)